TLR4 and adenomyosis: Moreover, nonsteroidal anti-inflammatory drugs (NSAIDs) provide partial symptomatic relief in adenomyosis, further implicate inflammatory pathways, such as IL-18 and TLR4, in adenomyosis pathogenesis 57.